O	0	11	Stimulation	Stimulation	NN	B-NP
O	12	14	of	of	IN	B-PP
B-Cell	15	26	endothelial	endothelial	JJ	B-NP
I-Cell	27	31	cell	cell	NN	I-NP
O	32	41	migration	migration	NN	I-NP
O	42	44	by	by	IN	B-PP
O	45	53	vascular	vascular	JJ	B-NP
O	54	66	permeability	permeability	NN	I-NP
O	67	73	factor	factor	NN	I-NP
O	73	74	/	/	SYM	B-NP
O	74	82	vascular	vascular	JJ	I-NP
O	83	94	endothelial	endothelial	JJ	I-NP
O	95	101	growth	growth	NN	I-NP
O	102	108	factor	factor	NN	I-NP
O	109	116	through	through	IN	B-PP
O	117	128	cooperative	cooperative	JJ	B-NP
O	129	139	mechanisms	mechanism	NNS	I-NP
O	140	149	involving	involve	VBG	B-VP
O	150	153	the	the	DT	B-NP
O	154	165	alphavbeta3	alphavbeta3	NN	I-NP
O	166	174	integrin	integrin	NN	I-NP
O	174	175	,	,	,	O
O	176	187	osteopontin	osteopontin	NN	B-NP
O	187	188	,	,	,	O
O	189	192	and	and	CC	O
O	193	201	thrombin	thrombin	NN	B-NP
O	201	202	.	.	.	O

O	203	205	We	We	PRP	B-NP
O	206	210	have	have	VBP	B-VP
O	211	221	identified	identify	VBN	I-VP
O	222	229	several	several	JJ	B-NP
O	230	240	mechanisms	mechanism	NNS	I-NP
O	241	243	by	by	IN	B-PP
O	244	249	which	which	WDT	B-NP
O	250	253	the	the	DT	B-NP
O	254	264	angiogenic	angiogenic	JJ	I-NP
O	265	273	cytokine	cytokine	NN	I-NP
O	274	282	vascular	vascular	JJ	I-NP
O	283	295	permeability	permeability	NN	I-NP
O	296	302	factor	factor	NN	I-NP
O	302	303	/	/	SYM	B-NP
O	303	311	vascular	vascular	JJ	I-NP
O	312	323	endothelial	endothelial	JJ	I-NP
O	324	330	growth	growth	NN	I-NP
O	331	337	factor	factor	NN	I-NP
O	338	339	(	(	(	O
O	339	342	VPF	VPF	NN	B-NP
O	342	343	/	/	SYM	B-NP
O	343	347	VEGF	VEGF	NN	I-NP
O	347	348	)	)	)	O
O	349	355	likely	likely	RB	B-VP
O	356	365	regulates	regulate	VBZ	I-VP
B-Cell	366	377	endothelial	endothelial	JJ	B-NP
I-Cell	378	383	cells	cell	NNS	I-NP
O	384	385	(	(	(	O
B-Cell	385	387	EC	EC	NNS	B-NP
O	387	388	)	)	)	O
O	389	398	migration	migration	NN	B-NP
O	398	399	.	.	.	O

O	400	403	VPF	VPF	NN	B-NP
O	403	404	/	/	SYM	I-NP
O	404	408	VEGF	VEGF	NN	I-NP
O	409	416	induced	induce	VBD	B-VP
B-Cell	417	423	dermal	dermal	JJ	B-NP
I-Cell	424	437	microvascular	microvascular	JJ	I-NP
I-Cell	438	440	EC	EC	NN	I-NP
O	441	451	expression	expression	NN	I-NP
O	452	454	of	of	IN	B-PP
O	455	460	mRNAs	mRNA	NNS	B-NP
O	461	469	encoding	encode	VBG	B-VP
O	470	473	the	the	DT	B-NP
O	474	480	alphav	alphav	NN	I-NP
O	481	484	and	and	CC	I-NP
O	485	490	beta3	beta3	NN	I-NP
O	491	499	integrin	integrin	NN	I-NP
O	500	508	subunits	subunit	NNS	I-NP
O	509	518	resulting	result	VBG	B-VP
O	519	521	in	in	IN	B-PP
O	522	531	increased	increase	VBN	B-NP
O	532	538	levels	level	NNS	I-NP
O	539	541	of	of	IN	B-PP
O	542	545	the	the	DT	B-NP
O	546	557	alphavbeta3	alphavbeta3	NN	I-NP
O	558	569	heterodimer	heterodimer	NN	I-NP
O	570	572	at	at	IN	B-PP
O	573	576	the	the	DT	B-NP
B-Cellular_component	577	581	cell	cell	NN	I-NP
I-Cellular_component	582	589	surface	surface	NN	I-NP
O	589	590	,	,	,	O
O	591	594	and	and	CC	O
O	595	598	VPF	VPF	NN	B-NP
O	598	599	/	/	SYM	O
O	599	603	VEGF	VEGF	NN	B-NP
O	604	608	also	also	RB	B-ADVP
O	609	616	induced	induce	VBD	B-VP
O	617	621	mRNA	mRNA	NN	B-NP
O	622	630	encoding	encode	VBG	B-VP
O	631	642	osteopontin	osteopontin	NN	B-NP
O	643	644	(	(	(	O
O	644	647	OPN	OPN	NN	B-NP
O	647	648	)	)	)	O
O	648	649	,	,	,	O
O	650	652	an	an	DT	B-NP
O	653	664	alphavbeta3	alphavbeta3	NN	I-NP
O	665	671	ligand	ligand	NN	I-NP
O	671	672	.	.	.	O

O	673	676	OPN	OPN	NN	B-NP
O	677	685	promoted	promote	VBD	B-VP
B-Cell	686	688	EC	EC	NN	B-NP
O	689	698	migration	migration	NN	I-NP
O	699	701	in	in	FW	B-ADVP
O	702	707	vitro	vitro	FW	I-ADVP
O	707	708	;	;	:	O
O	709	712	and	and	CC	O
O	713	716	VPF	VPF	NN	B-NP
O	716	717	/	/	SYM	I-NP
O	717	721	VEGF	VEGF	NN	I-NP
O	722	731	induction	induction	NN	I-NP
O	732	734	of	of	IN	B-PP
O	735	746	alphavbeta3	alphavbeta3	NN	B-NP
O	747	750	was	be	VBD	B-VP
O	751	762	accompanied	accompany	VBN	I-VP
O	763	765	by	by	IN	B-PP
O	766	775	increased	increase	VBN	B-NP
B-Cell	776	778	EC	EC	NN	I-NP
O	779	788	migration	migration	NN	I-NP
O	789	795	toward	toward	IN	B-PP
O	796	799	OPN	OPN	NN	B-NP
O	799	800	.	.	.	O

O	801	808	Because	Because	IN	B-SBAR
O	809	817	thrombin	thrombin	NN	B-NP
O	818	826	cleavage	cleavage	NN	I-NP
O	827	829	of	of	IN	B-PP
O	830	833	OPN	OPN	NN	B-NP
O	834	841	results	result	VBZ	B-VP
O	842	844	in	in	IN	B-PP
O	845	856	substantial	substantial	JJ	B-NP
O	857	868	enhancement	enhancement	NN	I-NP
O	869	871	of	of	IN	B-PP
O	872	875	OPN	OPN	NN	B-NP
O	875	876	'	'	POS	B-NP
O	876	877	s	s	JJ	I-NP
O	878	886	adhesive	adhesive	JJ	I-NP
O	887	897	properties	property	NNS	I-NP
O	897	898	,	,	,	O
O	899	902	and	and	CC	O
O	903	910	because	because	IN	B-SBAR
O	911	914	VPF	VPF	NN	B-NP
O	914	915	/	/	SYM	B-NP
O	915	919	VEGF	VEGF	NN	I-NP
O	920	928	promotes	promote	VBZ	B-VP
O	929	938	increased	increase	VBN	I-VP
B-Tissue	939	952	microvascular	microvascular	JJ	B-NP
O	953	965	permeability	permeability	NN	I-NP
O	966	973	leading	lead	VBG	B-VP
O	974	976	to	to	TO	B-PP
O	977	987	activation	activation	NN	B-NP
O	988	990	of	of	IN	B-PP
O	991	994	the	the	DT	B-NP
O	995	1004	extrinsic	extrinsic	JJ	I-NP
O	1005	1016	coagulation	coagulation	NN	I-NP
O	1017	1024	pathway	pathway	NN	I-NP
O	1024	1025	,	,	,	O
O	1026	1028	we	we	PRP	B-NP
O	1029	1033	also	also	RB	B-ADVP
O	1034	1046	investigated	investigate	VBD	B-VP
O	1047	1054	whether	whether	IN	B-SBAR
O	1055	1058	VPF	VPF	NN	B-NP
O	1058	1059	/	/	SYM	B-NP
O	1059	1063	VEGF	VEGF	NN	I-NP
O	1064	1075	facilitates	facilitate	VBZ	B-VP
O	1076	1084	thrombin	thrombin	NN	B-NP
O	1085	1093	cleavage	cleavage	NN	I-NP
O	1094	1096	of	of	IN	B-PP
O	1097	1100	OPN	OPN	NN	B-NP
O	1101	1103	in	in	FW	B-ADVP
O	1104	1108	vivo	vivo	FW	I-ADVP
O	1108	1109	.	.	.	O

O	1110	1120	Consistent	Consistent	JJ	B-ADJP
O	1121	1125	with	with	IN	B-PP
O	1126	1130	this	this	DT	B-NP
O	1131	1141	hypothesis	hypothesis	NN	I-NP
O	1141	1142	,	,	,	O
O	1143	1145	co	co	AFX	B-NP
O	1145	1146	-	-	HYPH	I-NP
O	1146	1155	injection	injection	NN	B-NP
O	1156	1158	of	of	IN	B-PP
O	1159	1162	VPF	VPF	NN	B-NP
O	1162	1163	/	/	SYM	B-NP
O	1163	1167	VEGF	VEGF	NN	I-NP
O	1168	1176	together	together	RB	B-ADVP
O	1177	1181	with	with	IN	B-PP
O	1182	1185	OPN	OPN	NN	B-NP
O	1186	1194	resulted	result	VBD	B-VP
O	1195	1197	in	in	IN	B-PP
O	1198	1203	rapid	rapid	JJ	B-NP
O	1204	1212	cleavage	cleavage	NN	I-NP
O	1213	1215	of	of	IN	B-PP
O	1216	1219	OPN	OPN	NN	B-NP
O	1220	1222	by	by	IN	B-PP
O	1223	1233	endogenous	endogenous	JJ	B-NP
O	1234	1242	thrombin	thrombin	NN	I-NP
O	1242	1243	.	.	.	O

O	1244	1255	Furthermore	Furthermore	RB	B-ADVP
O	1255	1256	,	,	,	O
O	1257	1259	in	in	IN	B-PP
O	1260	1270	comparison	comparison	NN	B-NP
O	1271	1275	with	with	IN	B-PP
O	1276	1282	native	native	JJ	B-NP
O	1283	1286	OPN	OPN	NN	I-NP
O	1286	1287	,	,	,	O
O	1288	1296	thrombin	thrombin	NN	B-NP
O	1296	1297	-	-	HYPH	B-VP
O	1297	1304	cleaved	cleave	VBN	B-NP
O	1305	1308	OPN	OPN	NN	I-NP
O	1309	1319	stimulated	stimulate	VBD	B-VP
O	1320	1321	a	a	DT	B-NP
O	1322	1329	greater	great	JJR	I-NP
O	1330	1334	rate	rate	NN	I-NP
O	1335	1337	of	of	IN	B-PP
B-Cell	1338	1340	EC	EC	NN	B-NP
O	1341	1350	migration	migration	NN	I-NP
O	1351	1353	in	in	FW	B-ADVP
O	1354	1359	vitro	vitro	FW	I-ADVP
O	1359	1360	,	,	,	O
O	1361	1366	which	which	WDT	B-NP
O	1367	1370	was	be	VBD	B-VP
O	1371	1379	additive	additive	JJ	B-ADJP
O	1380	1382	to	to	TO	B-PP
O	1383	1386	the	the	DT	B-NP
O	1387	1396	increased	increase	VBN	I-NP
O	1397	1406	migration	migration	NN	I-NP
O	1407	1417	associated	associate	VBN	B-VP
O	1418	1422	with	with	IN	B-PP
O	1423	1432	induction	induction	NN	B-NP
O	1433	1435	of	of	IN	B-PP
O	1436	1441	alpha	alpha	SYM	B-NP
O	1442	1443	v	v	NN	I-NP
O	1444	1448	beta	beta	SYM	B-NP
O	1449	1450	3	3	CD	I-NP
O	1450	1451	.	.	.	O

O	1452	1456	Thus	Thus	RB	B-ADVP
O	1456	1457	,	,	,	O
O	1458	1463	these	these	DT	B-NP
O	1464	1468	data	datum	NNS	I-NP
O	1469	1480	demonstrate	demonstrate	VBP	B-VP
O	1481	1492	cooperative	cooperative	JJ	B-NP
O	1493	1503	mechanisms	mechanism	NNS	I-NP
O	1504	1507	for	for	IN	B-PP
O	1508	1511	VPF	VPF	NN	B-NP
O	1511	1512	/	/	SYM	O
O	1512	1516	VEGF	VEGF	NN	B-NP
O	1517	1527	regulation	regulation	NN	I-NP
O	1528	1530	of	of	IN	B-PP
B-Cell	1531	1533	EC	EC	NN	B-NP
O	1534	1543	migration	migration	NN	I-NP
O	1544	1553	involving	involve	VBG	B-VP
O	1554	1557	the	the	DT	B-NP
O	1558	1569	alphavbeta3	alphavbeta3	NN	I-NP
O	1570	1578	integrin	integrin	NN	I-NP
O	1578	1579	,	,	,	O
O	1580	1583	the	the	DT	B-NP
O	1584	1595	alphavbeta3	alphavbeta3	NN	I-NP
O	1596	1602	ligand	ligand	NN	I-NP
O	1603	1606	OPN	OPN	NN	I-NP
O	1606	1607	,	,	,	O
O	1608	1611	and	and	CC	O
O	1612	1620	thrombin	thrombin	NN	B-NP
O	1621	1629	cleavage	cleavage	NN	I-NP
O	1630	1632	of	of	IN	B-PP
O	1633	1636	OPN	OPN	NN	B-NP
O	1636	1637	.	.	.	O

O	1638	1643	These	These	DT	B-NP
O	1644	1652	findings	finding	NNS	I-NP
O	1653	1657	also	also	RB	B-ADVP
O	1658	1668	illustrate	illustrate	VBP	B-VP
O	1669	1671	an	an	DT	B-NP
O	1672	1683	operational	operational	JJ	I-NP
O	1684	1688	link	link	NN	I-NP
O	1689	1696	between	between	IN	B-PP
O	1697	1700	VPF	VPF	NN	B-NP
O	1700	1701	/	/	SYM	I-NP
O	1701	1705	VEGF	VEGF	NN	I-NP
O	1706	1715	induction	induction	NN	I-NP
O	1716	1718	of	of	IN	B-PP
B-Cell	1719	1721	EC	EC	NN	B-NP
O	1722	1726	gene	gene	NN	I-NP
O	1727	1737	expression	expression	NN	I-NP
O	1738	1741	and	and	CC	O
O	1742	1745	VPF	VPF	NN	B-NP
O	1745	1746	/	/	SYM	B-NP
O	1746	1750	VEGF	VEGF	NN	I-NP
O	1751	1762	enhancement	enhancement	NN	I-NP
O	1763	1765	of	of	IN	B-PP
B-Tissue	1766	1779	microvascular	microvascular	JJ	B-NP
O	1780	1792	permeability	permeability	NN	I-NP
O	1792	1793	,	,	,	O
O	1794	1804	suggesting	suggest	VBG	B-VP
O	1805	1809	that	that	IN	B-SBAR
O	1810	1815	these	these	DT	B-NP
O	1816	1824	distinct	distinct	JJ	I-NP
O	1825	1835	biological	biological	JJ	I-NP
O	1836	1846	activities	activity	NNS	I-NP
O	1847	1850	may	may	MD	B-VP
O	1851	1854	act	act	VB	I-VP
O	1855	1866	accordingly	accordingly	RB	B-ADVP
O	1867	1869	to	to	TO	B-VP
O	1870	1879	stimulate	stimulate	VB	I-VP
B-Cell	1880	1882	EC	EC	NN	B-NP
O	1883	1892	migration	migration	NN	I-NP
O	1893	1899	during	during	IN	B-PP
O	1900	1912	angiogenesis	angiogenesis	NN	B-NP
O	1912	1913	.	.	.	O

